Neurotherapeutics Pharmacology
Targeting the transcription factor SPI1 attenuates neuroinflammation and dopaminergic degeneration in Parkinson’s disease via the tim-3/NF-κb axis
The publisher did not provide an abstract — full text is available via the link below.